29 October 2015 - The US FDA has approved the dual combination bronchodilator Utibron Neohaler (indacaterol/glycopyrrolate) inhalation powder for the long-term maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease, including chronic bronchitis and/or emphysema.

For more details, go to: http://www.us.novartis.com/info/newsroom/news-description.jsp?id=137236